BVS - Total Utang marang Modal Bioventus

Bioventus Corp (BVS) - logo korporat

A strong team of healing experts and a sophisticated sales system support the human capital potential of Bioventus Inc. (BVS). The total debt-to-equity ratio demonstrates the current debt load, where 1.09 characterizes this valuation parameter. Stable demand for mature orthopedic solutions, combined with the expansion strategy of Exogen systems in US clinics, ensures margin protection and growth in business value.

BVS: Rasio Total Utang marang Ekuitas bioventus.com 04.07.2022 - 30.10.2026
Produk dadi Bioventus Inc.

For Bioventus Inc. (BVS), this indicator serves as a measure of financial stability during a period of business transformation. The ratio of total liabilities to equity on the debt-to-equity chart determines the share of borrowed financing within the balance sheet structure. An increase in this metric signals insolvency risks, while a decrease indicates deleveraging. Amid restructuring and asset sales, this figure reflects the efficiency of reducing the debt load. It is critical for investors to track the downward trend of this ratio to confirm the success of the model pivot.

Analisis pesaing

Utang marang Ekuitas Boston Scientific Corporation|Edwards - Utang Agregat marang Ekuitas|Total Utang marang Modal RMD|PODD - Utang marang Modal|Total Utang marang Modal ZBH (Zimmer Biomet Corp)|COO - Rasio Total Utang marang Ekuitas|Align Technology - Total Utang marang Modal|Koefisien Total Utang marang Modal Globus Medical Inc GMED|TMDX: Total Utang marang Modal|Alphatec Corp (ATEC) - Total Utang marang Modal|Utang marang Ekuitas Artivion, Inc.|Utang marang Ekuitas ENOV|Total Utang marang Modal IART|Koefisien Total Utang marang Modal Establishment Labs Corp|Beta Bionics Corp - Rasio Total Utang marang Ekuitas|IRMD (IRADIMED Inc.) - Utang Agregat marang Ekuitas|Embecta Corp. - Total Utang marang Modal|Utang marang Modal tandemdiabetes.com|AXGN: Total Utang marang Modal|Rasio Utang marang Ekuitas SIBN|Rasio Total Utang marang Ekuitas OFIX|KIDS: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Treace Medical Concepts (TMCI)|Rasio Total Utang marang Ekuitas blade.com SRTA|Total Utang marang Modal CARL (Carlsmed)|RxSight Inc (RXST) - Utang marang Modal|ClearPoint - Total Utang marang Modal|STXS (Stereotaxis Corporation) - Rasio Utang marang Ekuitas|STIM: Total Utang marang Modal|SGHT - Koefisien Total Utang marang Modal|OBIO (Orchestra BioMed, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Anika (ANIK)|Total Utang marang Modal NSPR|Total Utang marang Modal zhjmedical.com (ZJYL)|Utang marang Ekuitas Vivani Medical VANI|Xtant Medical Holdings, Inc. - Utang marang Ekuitas|NMTC: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi MODD (Modular Medical)|MYO: Total Utang marang Modal|Utang marang Modal Envoy Medical Inc (COCH)|Utang marang Ekuitas Vivos Therapeutics|NVNO - Rasio Utang marang Modal|Rasio Total Utang marang Ekuitas SINT (Sintx Technologies)|Total Utang marang Modal Tenon Medical Inc. (TNON)|Total Utang marang Modal LFWD (ReWalk Robotics Ltd)|Koefisien Total Utang marang Modal Autonomix Medical Inc. (AMIX)|IVF - Utang marang Ekuitas|Utang Agregat marang Ekuitas BBLG|Axonics (AXNX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas BIOLASE Inc.|DYNT (Dynatronics Corp) - Total Utang marang Modal|Utang marang Modal Paragon 28 Corp FNA|Utang marang Ekuitas INVO Bioscience, Inc. (INVO)